The association between urinary kidney injury molecule 1 and urinary cadmium in elderly during long-term, low-dose cadmium exposure: A pilot study

Environmental Health: A Global Access Science Source

Volumn 10, Issue 1, 2011, Pages

  Pennemans, Valérie ^a   De Winter, Liesbeth M ^a   Munters, Elke ^a   Nawrot, Tim S ^a,b   Van Kerkhove, Emmy ^a   Rigo, Jean Michel ^a   Reynders, Carmen ^c   Dewitte, Harrie ^b,d   Carleer, Robert ^a   Penders, Joris ^a,c   Swennen, Quirine ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d Primary Health Care Center GVHV   (Belgium)

Author keywords

cadmium; chronic; kidney; kidney injury molecule 1; renal biomarkers; toxicity

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; CADMIUM; CREATININE; KIDNEY INJURY MOLECULE 1; ALBUMINOID; ALPHA GLOBULIN; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

BIOMARKER; BLOOD; BODY MASS; CADMIUM; COHORT ANALYSIS; DOSE-RESPONSE RELATIONSHIP; EXPERIMENTAL STUDY; INJURY; LONG-TERM CHANGE; MOLECULAR ANALYSIS; POLLUTION EXPOSURE; RODENT; SAMPLING; TOXICITY;

AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; POLLUTION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; UREA NITROGEN BLOOD LEVEL; URINALYSIS; BELGIUM; CHEMICALLY INDUCED DISORDER; ENVIRONMENTAL EXPOSURE; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; PATHOLOGY; PILOT STUDY; PROTEINURIA; URINE;

RATTUS;

AGED; ALBUMINS; ALPHA-GLOBULINS; BELGIUM; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CADMIUM; CREATININE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PILOT PROJECTS; PROTEINURIA; RECEPTORS, VIRUS;

EID: 80052305731     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-10-77     Document Type: Article

References (45)

1. Cadmium exposure in the population: from health risks to strategies of prevention. Nawrot TS, Staessen JA, Roels HA, Munters E, Cuypers A, Richart T, Ruttens A, Smeets K, Clijsters H, Vangronsveld J, Biometals 2010 23 769 82 10.1007/s10534-010-9343-z 20517707
2. Cadmium & its adverse effects on human health. Bernard A, Indian J Med Res 2008 128 557 564 19106447
3. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Staessen JA, Roels HA, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R, Lancet 1999 353 1140 1144 10.1016/S0140-6736(98)09356-8 10209978 (Pubitemid 29155207)
4. Common mechanisms in nephropathy induced by toxic metals. Sabolic I, Nephron Physiol 2006 104 107 114 10.1159/000095539 (Pubitemid 44570356)
5. Cadmium overload and toxicity. Jarup L, Nephrol Dial Transplant 2002 17 Suppl 2 35 39 12386256 (Pubitemid 34413724)
6. Critical evaluation of alpha1- and beta2-microglobulins in urine as markers of cadmium-induced tubular dysfunction. Ikeda M, Ezaki T, Tsukahara T, Moriguchi J, Furuki K, Fukui Y, Ukai SH, Sakurai H, Biometals 2004 17 539 541 15688860 (Pubitemid 41214264)
7. Renal function and historical environmental cadmium pollution from zinc smelters. Staessen JA, Lauwerys RR, Ide G, Roels HA, Vyncke G, Amery A, Lancet 1994 343 1523 1527 10.1016/S0140-6736(94)92936-X 7911869 (Pubitemid 24180048)
8. Prevalence of kidney dysfunction in humans-relationship to cadmium dose, metallothionein, immunological and metabolic factors. Nordberg GF, Jin T, Wu X, Lu J, Chen L, Lei L, Hong F, Nordberg M, Biochimie 2009 91 1282 1285 10.1016/j.biochi.2009.06.014 19563860
9. Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Bernard AM, Thielemans NO, Lauwerys RR, Kidney Int Suppl 1994 47 34 37 7532741
10. Biological monitoring for occupational cadmium exposure: the urinary metallothionein. Shaikh ZA, Ellis KJ, Subramanian KS, Greenberg A, Toxicology 1990 63 53 62 10.1016/0300-483X(90)90068-R 2382269 (Pubitemid 20223225)
11. Critical exposure level of cadmium for elevated urinary metallothionein - an occupational population study in China. Chen L, Jin T, Huang B, Nordberg G, Nordberg M, Toxicol Appl Pharmacol 2006 215 93 99 10.1016/j.taap.2006.01.013 16510161 (Pubitemid 44164381)
12. Cadmium and health: the Belgian experience. Bernard A, Roels H, Buchet JP, Cardenas A, Lauwerys R, IARC Sci Publ 1992 15 33
13. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Roels HA, Hoet P, Lison D, Ren Fail 1999 21 251 262 10.3109/08860229909085087 10416202 (Pubitemid 29318191)
14. Excretion of urinary cadmium, copper, and zinc in cadmium-exposed and nonexposed subjects, with special reference to urinary excretion of beta2-microglobulin and metallothionein. Nakajima M, Kobayashi E, Suwazono Y, Uetani M, Oishi M, Inaba T, Kido T, Shaikh ZA, Nogawa K, Biol Trace Elem Res 2005 108 17 31 10.1385/BTER:108:1-3:017 16327056 (Pubitemid 41752496)
15. Alpha 1-microglobulin (HC protein) in human hepatocellular carcinoma. Vincent C, Kew MC, Bouic P, Flacher M, Revillard JP, Br J Cancer 1989 59 415 416 10.1038/bjc.1989.83 2467685 (Pubitemid 19100009)
16. Development of an immunoenzymometric assay for alpha 1-microglobulin and measurement of its serum concentration in normal and HIV-infected persons. Porstmann T, Schmechta H, Hentschel C, Doepel H, Pas P, Becker J, Pergande M, Jung K, Nugel E, J Clin Chem Clin Biochem 1990 28 669 675 1704407 (Pubitemid 20346935)
17. Serum contents of the free forms of alpha(1)-microglobulin and ulinastatin: relation to diseased states in patients with mood disorders. Shikimi T, Kaku K, Uegaki J, Inagaki T, Seno H, Ishino H, Takaori S, Neuropsychobiology 2001 43 145 149 10.1159/000054883 11287793 (Pubitemid 32268585)
18. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M, J Biol Chem 1998 273 4135 4142 10.1074/jbc.273.7.4135 9461608 (Pubitemid 28103282)
19. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. Bailly V, Zhang Z, Meier W, Cate R, Sanicola M, Bonventre JV, J Biol Chem 2002 277 39739 39748 10.1074/jbc.M200562200 12138159 (Pubitemid 35190957)
20. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA, J Pathol 2007 212 209 217 10.1002/path.2175 17471468 (Pubitemid 46852099)
21. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV, Am J Physiol Renal Physiol 2006 290 517 529 10.1152/ajprenal.00291.2005 16174863 (Pubitemid 43725006)
22. Identification of putative gene based markers of renal toxicity. Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, Kramer J, Hamadeh HK, Collins J, Grissom S, Bennett L, Tucker CJ, Wild S, Kind C, Oreffo V, Davis JW, Curtiss S, Naciff JM, Cunningham M, Tennant R, Stevens J, Car B, Bertram TA, Afshari CA, Environ Health Perspect 2004 112 465 479 10.1289/ehp.6683 15033597 (Pubitemid 38404558)
23. Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Prozialeck WC, Vaidya VS, Liu J, Waalkes MP, Edwards JR, Lamar PC, Bernard AM, Dumont X, Bonventre JV, Kidney Int 2007 72 985 993 10.1038/sj.ki.5002467 17687258 (Pubitemid 47530576)
24. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL, Toxicol Sci 2008 101 159 170 17934191 (Pubitemid 350239020)
25. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL, J Am Soc Nephrol 2007 18 904 912 10.1681/ASN.2006030221 17267747 (Pubitemid 46434507)
26. Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Boventre JV, Clin Transl Sci 2008 1 200 208 10.1111/j.1752-8062.2008.00053.x 19212447 (Pubitemid 352831522)
27. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV, Kidney Int 2002 62 237 244 10.1046/j.1523-1755.2002.00433.x 12081583 (Pubitemid 34754067)
28. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ, Transplantation 2007 84 1625 1630 10.1097/01.tp. 0000295982.78039.ef 18165774
29. Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. Prozialeck WC, Edwards JR, Lamar PC, Liu J, Vaidya VS, Bonventre JV, Toxicol Appl Pharmacol 2009 306 314
30. Preclinical Evaluation of Novel Urinary Biomarkers of Cadmium Nephrotoxicity. Prozialeck WC, Edwards JR, Vaidya VS, Bonventre JV, Toxicol Appl Pharmacol 2009 238 301 305 10.1016/j.taap.2009.01.012 19371616
31. Early biomarkers of cadmium exposure and nephrotoxicity. Prozialeck WC, Edwards JR, Biometals 2010 23 793 809 10.1007/s10534-010-9288-2 20107869
32. The denominator in general practice, a new approach from the Intego database. Bartholomeeusen S, Kim CY, Mertens R, Faes C, Buntinx F, Fam Pract 2005 22 442 447 10.1093/fampra/cmi054 15964863 (Pubitemid 41487381)
33. Assay validation for KIM-1: human urinary renal dysfunction biomarker. Chaturvedi S, Farmer T, Kapke GF, Int J Biol Sci 2009 5 128 134 19173034
34. Effect of pH on the stability of kidney injury molecule 1 (KIM-1) and on the accuracy of its measurement in human urine. Pennemans V, De Winter LM, Faes C, Van Kerkhove E, Reynders C, Rigo JM, Swennen Q, Penders J, Clin Chim Acta 2010 411 2083 2086 10.1016/j.cca.2010.09.008 20837000
35. Screening for kidney diseases: older measures versus novel biomarkers. Wu I, Parikh CR, Clin J Am Soc Nephrol 2008 3 1895 1901 10.2215/CJN.02030408 18922990
36. Closer correlation of cadmium in urine than that of cadmium in blood with tubular dysfunction markers in urine among general women populations in Japan. Ikeda M, Ohashi F, Fukui Y, Sakuragi S, Moriguchi J, Int Arch Occup Environ Health 2010 84 121 9 20364267
37. Air quality guidelines for Europe. WHO, WHO Reg Publ Eur Ser 2000 V-X 1 273
38. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T, Nishijo M, Nakagawa H, Nogawa K, Environ Res 2006 101 401 406 10.1016/j.envres.2005.12.002 16436274 (Pubitemid 43782668)
39. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV, Nat Biotechnol 2010 28 5 478 485 10.1038/nbt.1623 20458318
40. Alpha1-microglobulin is stable in human urine ex vivo. Payn MM, Webb MC, Lawrence D, Lamb EJ, Clin Chem 2002 48 1136 1138 12089198 (Pubitemid 34680925)
41. Urinary alpha 1 microglobulin in lead workers. Endo G, Konishi Y, Kiyota A, Horiguchi S, Bull Environ Contam Toxicol 1993 50 744 749 7683940 (Pubitemid 23129258)
42. Renal dysfunction induced by cadmium: biomarkers of critical effects. Bernard A, Biometals 2004 17 519 523 15688856 (Pubitemid 41214260)
43. Biomarkers of acute kidney injury. Vaidya VS, Ferguson MA, Bonventre JV, Annu Rev Pharmacol Toxicol 2008 48 463 493 10.1146/annurev.pharmtox.48.113006. 094615 17937594 (Pubitemid 351738161)
44. Cell adhesion molecules in chemically-induced renal injury. Prozialeck WC, Edwards JR, Pharmacol Ther 2007 114 74 93 10.1016/j.pharmthera.2007.01.001 17316817 (Pubitemid 46498159)
45. On the behaviour of cysteine as ligand of cadmium(II). Bottari E, Festa MR, Talanta 1997 44 1705 1718 10.1016/S0039-9140(97)00015-5 18966910 (Pubitemid 27354195)